Genetic Animal Models for Arrhythmogenic Cardiomyopathy
Open Access
- 24 June 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 11, 624
- https://doi.org/10.3389/fphys.2020.00624
Abstract
Arrhythmogenic cardiomyopathy has been clinically defined since the 1980s and causes right or biventricular cardiomyopathy associated with ventricular arrhythmia. Although it is a rare cardiac disease, it is responsible for a significant proportion of sudden cardiac deaths, especially in athletes. The majority of patients with arrhythmogenic cardiomyopathy carry one or more genetic variants in desmosomal genes. In the 1990s, several knockout mouse models of genes encoding for desmosomal proteins involved in cell-cell adhesion revealed for the first time embryonic lethality due to cardiac defects. Influenced by these initial discoveries in mice, arrhythmogenic cardiomyopathy received an increasing interest in human cardiovascular genetics, leading to the discovery of mutations initially in desmosomal genes and later on in more than 25 different genes. Of note, even in the clinic, routine genetic diagnostics are important for risk prediction of patients and their relatives with arrhythmogenic cardiomyopathy. Based on improvements in genetic animal engineering, different transgenic, knock-in, or cardiac-specific knockout animal models for desmosomal and nondesmosomal proteins have been generated, leading to important discoveries in this field. Here, we present an overview about the existing animal models of arrhythmogenic cardiomyopathy with a focus on the underlying pathomechanism and its importance for understanding of this disease. Prospectively, novel mechanistic insights gained from the whole animal, organ, tissue, cellular, and molecular levels will lead to the development of efficient personalized therapies for treatment of arrhythmogenic cardiomyopathy.Funding Information
- Bundesministerium für Bildung und Forschung
This publication has 242 references indexed in Scilit:
- The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPaseJournal of Molecular and Cellular Cardiology, 2012
- Desmoglein 2 mutant mice develop cardiac fibrosis and dilationBasic Research in Cardiology, 2011
- Genome-wide association identifies a deletion in the 3′ untranslated region of Striatin in a canine model of arrhythmogenic right ventricular cardiomyopathyHuman Genetics, 2010
- Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular CardiomyopathyJournal of the American College of Cardiology, 2010
- Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based diseaseJournal of Molecular and Cellular Cardiology, 2009
- The vertebrate muscle Z-disc: sarcomere anchor for structure and signallingJournal of Muscle Research and Cell Motility, 2009
- Mutations in Ribonucleic Acid Binding Protein Gene Cause Familial Dilated CardiomyopathyJournal of the American College of Cardiology, 2009
- Plakoglobin has both structural and signalling roles in zebrafish developmentDevelopmental Biology, 2009
- Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 GeneAmerican Journal of Human Genetics, 2008
- Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system diseaseJournal of Molecular and Cellular Cardiology, 2008